Vimarsana
Biggest News Aggregation in the World

Page 20 - Kesson Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kesson Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kesson Corp Today - Breaking & Trending Today

UPDATE 4-J&J, other drugmakers go to trial in California in $50 bln case over 'deadly legacy' of opioids - Vimarsana News

UPDATE 4-J&J, other drugmakers go to trial in California in $50 bln case over 'deadly legacy' of opioids

UPDATE 4-J&J, other drugmakers go to trial in California in $50 bln case over 'deadly legacy' of opioids Reuters 1 hr ago (Adds argument from J&J's counsel) Popular Searches By Nate Raymond and Brendan Pierson April 19 (Reuters) - Four drugmakers helped cause the deadly U.S. opioid epidemic by deceptively marketing their drugs and downplaying their addictive risks, a lawyer for several California counties argued on Monday at the start of multibillion-dollar trial. Those counties accuse Johnson & Johnson, Teva Pharmaceutical Industries Ltd, Endo International Plc and AbbVie's Allergan unit o...

Source: msn.com
Drugmakers to face trial in California over claims they fueled opioid epidemic - Vimarsana News

Drugmakers to face trial in California over claims they fueled opioid epidemic

April 19, 2021 When it comes to the successes of President Joe Biden, his accomplishments are stacking up and his approval rating is proving Americans are happy, particularly with the economy. According to Forbes, there's a reason for celebration, because the Biden stock market is rivaling that of former President Donald Trump FiveThirtyEight, which charts poll numbers to formulate the mean data, shows that Biden enjoys an approval of over 53 percent and a disapproval of 40.6 percent. Meanwhile, former President Donald Trump would be lucky to get an approval of 40.6 percent. The last...

Drug companies to face first opioid trial following pandemic delays - Vimarsana News

Drug companies to face first opioid trial following pandemic delays

By Syndicated Content By Nate Raymond and Brendan Pierson (Reuters) - Four drugmakers, including Johnson & Johnson and Teva Pharmaceutical Industries Ltd, will go to trial on Monday over claims they helped fuel an opioid crisis that has resulted in nearly 500,000 overdose deaths in the United States. The trial is one of several looking to hold companies accountable for the overdose and abuse crisis that are set to take place this year after the coronavirus pandemic delayed litigation, putting renewed pressure on them to enter into multi-billion dollar settlements. J&J, Teva Pharma...

Source: wsau.com
J&J COVID-19 vaccine shipping to U.S., but new deliveries hinge on regulators - Vimarsana News

J&J COVID-19 vaccine shipping to U.S., but new deliveries hinge on regulators

3 Min Read (Reuters) - Johnson & Johnson will ship nearly 4 million doses of its newly authorized single-dose COVID-19 vaccine around the United States this week, but a top executive said on Monday that the next round of deliveries is contingent on regulatory approvals at a new plant. The drugmaker expects to deliver another 16 million doses of the vaccine by the end of this month. But none is expected to go out next week. “Four million doses are already on trucks to different places in the U.S.,” J&J Chief Scientific Officer Paul Stoffels said in an interview, noting that those doses cam...

J&J Covid-19 Vaccine Authorized for Use in U.S. -- Update - Vimarsana News

J&J Covid-19 Vaccine Authorized for Use in U.S. -- Update

By Peter Loftus and Thomas M. Burton The first single-dose Covid-19 vaccine, a shot from Johnson & Johnson, was authorized for use, a big boost for a mass-vaccination campaign rushing to... | March 4, 2021